Article Image

IPFS News Link • Death

French Researchers Identify 'Improbably High Rate of Deaths' in Newborns Who Received New RS

• Daily News from the Art of Liberty Foundation

By Michael Nevradakis

French researchers identified possible safety signals in babies coinciding with the rollout of Beyfortus, a recently approved monoclonal antibody treatment for respiratory syncytial virus (RSV) in newborns.

The discovery comes as public health authorities ramp up warnings about the spread of respiratory viruses and step up their promotion of the drug.

In interviews with The Defender, the researchers — French independent scientist and author Hélène Banoun, Ph.D., and French statistician Christine Mackoi — explained that data from France's National Institute of Statistics and Economic Studies (INSEE) indicates an improbably high rate of deaths of babies between 2 and 6 days old in France during September and October 2023.


www.universityofreason.com/a/29887/KWADzukm